Management of Postmenopausal Vaginal Bleeding

Initial Assessment and Diagnostic Approach

The National Comprehensive Cancer Network recommends that any postmenopausal vaginal bleeding in an elderly patient must be presumed malignant until proven otherwise and requires immediate diagnostic evaluation with endometrial sampling or transvaginal ultrasound to rule out endometrial cancer 1, 2
Obtain complete medication history immediately, specifically asking about anticoagulants and antiplatelet agents, as these can precipitate or exacerbate bleeding 3
Perform speculum examination to identify the bleeding source, looking for cervical lesions, polyps, inflammation, vaginal atrophy, or lacerations 4
Avoid digital bimanual examination initially if the source is unclear until imaging excludes structural pathology 4

Complete blood count is essential to assess the degree of anemia and guide transfusion decisions 3
Coagulation studies, such as PT/INR and aPTT, are crucial, especially if the patient is on anticoagulation or has a bleeding diathesis 3
Endometrial biopsy is mandatory for any postmenopausal bleeding to exclude endometrial carcinoma, which occurs in approximately 10% of cases 1, 2
Office endometrial biopsy has a 10% false-negative rate, and if negative but bleeding persists, proceed to fractional dilation and curettage under anesthesia 2
Hysteroscopy may be helpful if persistent bleeding remains undiagnosed after initial workup, particularly to identify polyps or focal lesions 1, 2

If malignancy is identified, immediate referral to gynecologic oncology for staging and treatment planning is necessary 1, 2
Do not delay referral, as survival is significantly better with early-stage disease and appropriate specialist involvement 2
For anticoagulation-related bleeding, do not routinely discontinue anticoagulation unless bleeding is life-threatening or uncontrolled 3
For life-threatening bleeding on warfarin, administer 4-factor prothrombin complex concentrate plus 5 mg IV vitamin K, targeting INR <1.5 3
For DOAC-related bleeding, consider specific reversal agents only if bleeding is uncontrolled and DOAC levels are measurable 3

Never assume postmenopausal bleeding is benign, as approximately 10% of cases are endometrial cancer 1, 2
Do not accept a negative office endometrial biopsy as definitive if bleeding persists, and proceed to D&C under anesthesia 2

In postmenopausal women presenting with vaginal bleeding, transvaginal ultrasound is recommended as the first‑line imaging test to assess endometrial thickness and detect intrauterine pathology. 5

The American College of Radiology (ACR) Appropriateness Criteria classify transvaginal ultrasound as “usually appropriate” for the evaluation of abnormal uterine bleeding in this population. 5

Compared with transabdominal ultrasound, transvaginal ultrasound provides superior resolution, enabling more accurate visualization of the endometrium and identification of structural abnormalities such as polyps, masses, or endometrial thickening. 5

If transvaginal ultrasound cannot fully visualize the endometrium because of patient body habitus, uterine position, or the presence of leiomyomas or adenomyosis, pelvic MRI may be considered owing to its excellent soft‑tissue contrast and multiplanar capability. 5